Common Contracts
5 similar Executive Employment Agreement contracts by CinCor Pharma, Inc., HOOKIPA Pharma Inc.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • July 26th, 2024 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • North Carolina
This Executive Employment Agreement (the “Agreement”) is entered into effective as of July 22, 2024, by and between Mary Theresa Coelho (“Executive”) and HOOKIPA Pharma Inc. (the “Company”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 23rd, 2023 • CinCor Pharma, Inc. • Pharmaceutical preparations • New York
This EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) by and between Michael W. Kalb (“Executive”) and CinCor Pharma (the “Company”) is effective as of November 4, 2022 or such earlier or later day that Executive commences employment with the Company by agreement between the Company and Executive (such date that Executive commences employment, the “Effective Date”).
SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 3rd, 2022 • CinCor Pharma, Inc. • Pharmaceutical preparations • Ohio
This SECOND AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective as of, and conditional upon, the pricing date of the initial public offering of the common stock of the Company (the “Effective Date”), by and between Catherine Pearce (“Executive”) and CinCor Pharma, Inc. (the “Company”). This Agreement amends, restates, and supersedes in its entirety the Amended and Restated Employment Terms between the Company and Executive dated August 2, 2021 (the “Prior Agreement”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 3rd, 2022 • CinCor Pharma, Inc. • Pharmaceutical preparations • Massachusetts
This AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective as of, and conditional upon, the pricing date of the initial public offering of the common stock of the Company (the “Effective Date”), by and between Marc de Garidel (“Executive”) and CinCor Pharma, Inc. (the “Company”). This Agreement amends, restates, and supersedes in its entirety the Employment Agreement between the Company and Executive that was effective May 5, 2021 (the “Prior Agreement”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • January 3rd, 2022 • CinCor Pharma, Inc. • Pharmaceutical preparations • Massachusetts
This AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective as of, and conditional upon, the pricing date of the initial public offering of the common stock of the Company (the “Effective Date”), by and between Mary Theresa Coelho (“Executive”) and CinCor Pharma, Inc. (the “Company”). This Agreement amends, restates, and supersedes in its entirety the Employment Terms between the Company and Executive dated October 10, 2021 (the “Prior Agreement”).
